BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 23705966)

  • 1. Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.
    Giri AK; Hruby VJ
    Expert Opin Investig Drugs; 2014 Feb; 23(2):227-41. PubMed ID: 24329035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures.
    Blaine AT; van Rijn RM
    Neuropharmacology; 2023 Jul; 232():109526. PubMed ID: 37004753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder.
    Hampsey E; Jelen L; Young AH
    Expert Opin Emerg Drugs; 2024 May; ():1-12. PubMed ID: 38682267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta-opioid receptor-mediated modulation of excitability of individual hippocampal neurons: mechanisms involved.
    Moravcikova L; Moravcik R; Jezova D; Lacinova L; Dremencov E
    Pharmacol Rep; 2021 Feb; 73(1):85-101. PubMed ID: 33161533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the First Marine-Derived Opioid Receptor "Balanced" Agonist with a Signaling Profile That Resembles the Endorphins.
    Johnson TA; Milan-Lobo L; Che T; Ferwerda M; Lambu E; McIntosh NL; Li F; He L; Lorig-Roach N; Crews P; Whistler JL
    ACS Chem Neurosci; 2017 Mar; 8(3):473-485. PubMed ID: 27744679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated activation of delta opiod receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opiod receptors-mediated antiallodinic effect.
    Vicario N; Parenti R; Arico' G; Turnaturi R; Scoto GM; Chiechio S; Parenti C
    Mol Pain; 2016; 12():. PubMed ID: 27590071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel delta opioid receptor agonists with oxazatricyclodecane structure.
    Fujii H; Hayashida K; Saitoh A; Yokoyama A; Hirayama S; Iwai T; Nakata E; Nemoto T; Sudo Y; Uezono Y; Yamada M; Nagase H
    ACS Med Chem Lett; 2014 Apr; 5(4):368-72. PubMed ID: 24900842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of δ-opioid receptors in learning and memory underlying the development of addiction.
    Klenowski P; Morgan M; Bartlett SE
    Br J Pharmacol; 2015 Jan; 172(2):297-310. PubMed ID: 24641428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidepressant -like effects of delta-opioid receptor agonists.
    Jutkiewicz EM
    Mol Interv; 2006 Jun; 6(3):162-9. PubMed ID: 16809477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).
    Fujii H; Takahashi T; Nagase H
    Expert Opin Ther Pat; 2013 Sep; 23(9):1181-208. PubMed ID: 23705966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.
    Ananthan S
    AAPS J; 2006 Mar; 8(1):E118-25. PubMed ID: 16584118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.